Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 01 May 2015
At a glance
- Drugs Ofatumumab (Primary) ; Dexamethasone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 01 May 2015 Results published in the American Journal of Hematology.
- 03 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Mar 2011 New trial record